By February 13, 2013 Read More →

Rottenstein Law Group Responds to News That J&J Marketing Department Knew of Implant Risks

The Rottenstein Law Group continues to monitor DePuy ASR news and has learned that in the ongoing trial in Los Angeles Superior Court jurors were shown emails from Johnson & Johnson’s marketing department that indicated that the company knew of the hip implant’s risks well in advance of the August 2010 DePuy hip recall.

(PRWEB) February 12, 2013

The Rottenstein Law Group continues to monitor with concern DePuy ASR news and has learned that in the ongoing trial in Los Angeles Superior Court jurors were shown emails from Johnson & Johnson’s marketing department that indicated that the company knew of the hip implant’s risks well in advance of the August 2010 DePuy hip recall.

According to Bloomberg,* Paul Berman, marketing director for Johnson & Johnson subsidiary DePuy, wrote in September 2009 that he intended to “reiterate my concern” over the safety of the ASR hip implant because of device failure and metal poisoning. This was about 11 months before the recall. Berman added that a majority of surgeons recommended discontinuing the ASR because of problems.

Read more: DePuy Hip Recall News: Rottenstein Law Group Responds to News That J&J Marketing Department Knew of Implant Risks


Posted in: Health